ES397911A1 - Procedimiento para la obtencion de derivados de piperidina. - Google Patents

Procedimiento para la obtencion de derivados de piperidina.

Info

Publication number
ES397911A1
ES397911A1 ES397911A ES397911A ES397911A1 ES 397911 A1 ES397911 A1 ES 397911A1 ES 397911 A ES397911 A ES 397911A ES 397911 A ES397911 A ES 397911A ES 397911 A1 ES397911 A1 ES 397911A1
Authority
ES
Spain
Prior art keywords
compounds
translation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES397911A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5968670A external-priority patent/GB1356117A/en
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES397911A1 publication Critical patent/ES397911A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES397911A 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina. Expired ES397911A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5968670A GB1356117A (en) 1970-12-16 1970-12-16 1-3-cyano-3,3-diphenylpropyl-4-phenylpiperidine-4-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
ES397911A1 true ES397911A1 (es) 1975-04-16

Family

ID=10484227

Family Applications (4)

Application Number Title Priority Date Filing Date
ES397911A Expired ES397911A1 (es) 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina.
ES397912A Expired ES397912A1 (es) 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina.
ES400479A Expired ES400479A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.
ES400478A Expired ES400478A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES397912A Expired ES397912A1 (es) 1970-12-16 1971-12-13 Procedimiento para la obtencion de derivados de piperidina.
ES400479A Expired ES400479A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.
ES400478A Expired ES400478A1 (es) 1970-12-16 1972-03-06 Procedimiento para la obtencion de derivados de piperidina con actividad anti-diarreica.

Country Status (9)

Country Link
JP (1) JPS5542996B1 (enrdf_load_stackoverflow)
CA (1) CA918157A (enrdf_load_stackoverflow)
CY (1) CY925A (enrdf_load_stackoverflow)
DK (2) DK136037B (enrdf_load_stackoverflow)
ES (4) ES397911A1 (enrdf_load_stackoverflow)
IE (2) IE35890B1 (enrdf_load_stackoverflow)
SE (2) SE370543B (enrdf_load_stackoverflow)
YU (2) YU34991B (enrdf_load_stackoverflow)
ZA (2) ZA718380B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6115962U (ja) * 1984-06-30 1986-01-30 儀介 野沢 豚用飼槽

Also Published As

Publication number Publication date
IE35890B1 (en) 1976-06-23
YU34990B (en) 1980-06-30
IE35890L (en) 1972-06-16
YU248778A (en) 1979-12-31
IE35889B1 (en) 1976-06-23
DK136037B (da) 1977-08-01
SE370542B (enrdf_load_stackoverflow) 1974-10-21
YU248678A (en) 1979-12-31
CA918157A (en) 1973-01-02
ZA718379B (en) 1973-02-28
ES400479A1 (es) 1975-01-16
DK130966B (da) 1975-05-12
ES400478A1 (es) 1975-01-01
ES397912A1 (es) 1975-04-16
IE35889L (en) 1972-06-16
CY925A (en) 1977-12-23
ZA718380B (en) 1973-02-28
YU34991B (en) 1980-06-30
DK136037C (enrdf_load_stackoverflow) 1978-01-02
SE370543B (enrdf_load_stackoverflow) 1974-10-21
JPS5542996B1 (enrdf_load_stackoverflow) 1980-11-04
DK130966C (enrdf_load_stackoverflow) 1975-10-06

Similar Documents

Publication Publication Date Title
Lecoutey et al. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Dooley et al. Alteration of central alpha2-and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin
Mahata et al. Desensitization of catecholamine release: the novel catecholamine release-inhibitory peptide catestatin (chromogranin A344–364) acts at the receptor to prevent nicotinic cholinergic tolerance
Cao et al. Use of NK1 knockout mice to analyze substance P-induced edema formation
DasGupta et al. Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration
Mollica et al. Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
Leo et al. Intrathecal resiniferatoxin modulates TRPV1 in DRG neurons and reduces TNF‐induced pain‐related behavior
Antonio et al. Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation
RU2017106172A (ru) Применение антагонистов cxcr2 для предотвращения и/или лечения периферической невропатии, вызванной химиотерапией (cipn)
Costa et al. Involvement of vanilloid receptors and purinoceptors in the Phoneutria nigriventer spider venom-induced plasma extravasation in rat skin
ES397911A1 (es) Procedimiento para la obtencion de derivados de piperidina.
EP1707202A1 (de) Organische Verbindungen
Kim et al. Effects of some nicotine metabolites and related compounds on isolated smooth muscle
Bruban et al. Evidence for synergy between α2-adrenergic and nonadrenergic mechanisms in central blood pressure regulation
Papeschi Amantadine may stimulate dopamine and noradrenaline receptors
Maze From bench to bedside and back again: a personal journey with dexmedetomidine
Vellonen et al. Disease-induced alterations in brain drug transporters in animal models of Alzheimer’s disease
Albert Neurokinin antagonists and their potential role in treating depression and other stress disorders
Alanine et al. 1-Benzyloxy-4, 5-dihydro-1H-imidazol-2-yl-amines, a novel class of NR1/2B subtype selective NMDA receptor antagonists
Woolley et al. Differentiation between receptors for serotonin and tryptamine by means of the exquisite specificity of antimetabolites
Berger et al. Pentamidine analogs as inhibitors of [3H] MK-801 and [3H] ifenprodil binding to rat brain NMDA receptors
Ozbey et al. Serum N-Desmethylcitalopram concentrations are associated with the clinical response to citalopram of patients with major depression
Hansen-Schwartz et al. Endothelium-dependent relaxant responses to selective 5-HT1B/1D receptor agonists in the isolated middle cerebral artery of the rat
Abatematteo et al. Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect
Kim et al. Design, Synthesis, and Biological Evaluation of Imidazopyrazinone Derivatives as Antagonists of Inhibitor of Apoptosis Proteins (IAPs)